Abstract
Background: Unani Medicine (Tibb-e-Unani), with its historical roots in Greco-Arabic natural philosophy and systematized by Ibn Sina (Avicenna) and Al-Razi, represents a holistic, person-centered medical tradition grounded in the theory of humors (Akhlat), individual temperament (Mizaj), and physiological self-preservation (Tabi'at). Despite its widespread clinical adoption in South Asia, the Middle East, and Mediterranean corridors, its integration into mainstream global healthcare necessitates systematic harmonization with modern scientific and regulatory methodologies.
Aims & Scope: This inaugural editorial presents an evidence-based roadmap for the international propagation of Unani Medicine. We delineate four critical pillars: (i) standardization and molecular profiling of classical polyherbal formulations in Ilmul Advia; (ii) rigorous randomized controlled trials for regimenal modalities (Ilaj-bit-Tadbeer); (iii) translating qualitative temperamental diagnostics (Nabz, Baul, Baraz) into objective biophysical markers; and (iv) aligning with the World Health Organization (WHO) Traditional Medicine Strategy 2025–2034.
Conclusion: UNANImity stands committed to serving as an authentic, peer-reviewed global megaphone that bridges age-old traditional wisdom with reproducible pharmacological rigor, thereby securing Unani medicine’s rightful status in integrative 21st-century healthcare.
1. Introduction
For millennia, traditional and indigenous healing paradigms have offered comprehensive clinical answers to human affliction. Among these, the Unani System of Medicine (*Tibb-e-Unani*) occupies a distinguished intellectual lineage, tracing its foundational philosophy to Buqrat (Hippocrates), Galen, and subsequently enriched by seminal encyclopedists such as Ibn Sina (Avicenna, whose *Al-Qanun fi al-Tibb* served as Europe’s authoritative medical textbook for over five centuries) and Al-Razi (Rhazes) [1, 2].
Unlike reductionist paradigms that isolate pathological lesions to single molecular targets, Unani medicine conceptualizes health as a dynamic equilibrium between internal humors (*Akhlat-e-Arba'ah*: Dam/Blood, Balgham/Phlegm, Safra/Yellow Bile, and Sauda/Black Bile) and environmental determinants [3]. The innately endowed physiological intelligence, termed *Tabi'at Mudabbira-e-Badan*, serves as the supreme healing architect. When equilibrium is disrupted, disease manifests; the physician’s sacred role is merely to facilitate *Tabi'at* through gentle dietary modulation (*Ilaj-bil-Ghiza*), regimenal balance (*Ilaj-bit-Tadbeer*), and carefully calibrated pharmacotherapy (*Ilaj-bil-Dawa*) [4].
Classical Unani hygiene dictates that physiological harmony depends on equilibrium across six non-negotiable ambient factors: (1) Hawa-e-Muheet (ambient air and climate); (2) Makool-wa-Mashroob (nutritional intake and water); (3) Harkat-wa-Sukoon-e-Badani (physical exercise and rest); (4) Harkat-wa-Sukoon-e-Nafsani (emotional state and psychiatric equilibrium); (5) Naum-wa-Yaqzah (sleep and wakefulness cycles); and (6) Istifragh-wa-Ehtibas (retention of nutrients and evacuation of metabolic toxins). Contemporary chronobiology and preventive lifestyle medicine increasingly mirror these foundational precepts.
2. Classical Philosophy & Mizaj: Modern Biomarker Convergence
A persistent critique from biomedical skeptics asserts that classical Unani terminologies—such as hot (*Har*), cold (*Barid*), moist (*Ratab*), and dry (*Yabis*) temperaments—are abstract relics incapable of empirical validation. However, cutting-edge metabolomics, genomic expression arrays, and autonomic nervous system mapping have initiated a profound epistemological convergence [5].
Recent multi-omics investigations conducted across premier research centres demonstrate that individuals categorized as *Damawi* (Sanguine / Hot & Moist) exhibit elevated metabolic turnover, increased basal core temperatures, and distinct peripheral microcirculatory hemodynamic patterns. Conversely, individuals diagnosed with *Balghami* (Phlegmatic / Cold & Moist) temperaments present with lower basal metabolic rates (BMR), distinct lipidome clusters, and relative autonomic parasympathetic dominance [6].
| Mizaj (Temperament) | Dominant Humor (Khilt) | Classical Physical Characteristics | Biomedical & Physiological Correlates |
|---|---|---|---|
| Damawi (Sanguine) | Dam (Blood) | Warm, ruddy complexion, robust pulse, energetic posture | Elevated cardiac output, higher BMR, prominent peripheral perfusion, pro-inflammatory cytokine propensity |
| Safrawi (Choleric) | Safra (Yellow Bile) | Warm, yellowish tint, lean frame, sharp rapid pulse | High sympathetic tone, increased thyroidal signaling, rapid gastrointestinal transit time |
| Balghami (Phlegmatic) | Balgham (Phlegm) | Cool, pale skin, flaccid musculature, slow soft pulse | Lower basal metabolic rate, higher adipose index, parasympathetic dominance, lower serum albumin clearance |
| Saudawi (Melancholic) | Sauda (Black Bile) | Dry, dark complexion, hyper-reflective, slow wiry pulse | Elevated oxidative stress markers, altered platelet reactivity, increased cortisol/HPA axis tone |
3. Contemporary Validation Pillars in Ilmul Advia & Clinical Regimens
To achieve undisputed globalisation, the Unani fraternity must uphold the highest standards of analytical reproducibility and clinical ethics without compromising the holistic integrity of its compound formulations [7]. In this regard, three research priorities demand immediate institutional investment:
1. Chromatographic Fingerprinting & Reverse Pharmacology: Multi-ingredient compound formulations such as *Khamira Abresham Hakim Arshad Wala*, *Majun Dabeed-ul-Ward*, and *Jawarish Jalinoos* can no longer rely solely on organoleptic evaluation. High-Performance Thin-Layer Chromatography (HPTLC), High-Resolution Liquid Chromatography Mass Spectrometry (HR-LCMS), and DNA barcoding of raw botanical species must be systematically incorporated into the Unani Pharmacopoeia [8].
2. Randomised Controlled Trials for Regimenal Therapies (Ilaj-bit-Tadbeer): Regimenal modalities such as cupping (*Hijama*), leeches (*Ta'leeq*), massage (*Dalak*), and diaphoresis (*Tareeq*) have demonstrated remarkable empirical relief in chronic rheumatological and neurological conditions. However, multi-centre trials conforming to CONSORT-Extension guidelines for non-pharmacological interventions are urgently required to establish level-1 clinical evidence [9].
3. Pharmacovigilance & Heavy Metal Safety Benchmarks: As international regulatory scrutiny intensifies, establishing stringent microbial, pesticide, and heavy metal (Lead, Cadmium, Arsenic, Mercury) thresholds conforming to International Council for Harmonisation (ICH) and WHO standards is vital for market clearance in North America, Europe, and GCC jurisdictions [10].
4. Aligning with WHO Traditional Medicine Strategies
The declaration of the WHO Global Traditional Medicine Centre in Jamnagar, India, alongside the WHO Traditional Medicine Strategy, has created unprecedented geopolitical and scientific tailwinds for systems of indigenous medicine. The World Unani Foundation (WUF) recognizes that global integration demands harmonized terminology, standardized ICD-11 dual-coding for Unani diagnostic concepts, and documented educational curricula capable of cross-border credentialing [11].
Crucially, Unani medicine must position itself not as an antagonist to biomedicine, but as an indispensable integrative ally. In metabolic syndromic conditions, chronic pain syndromes, functional gut disorders, and palliative supportive oncology, the synergy of Unani dietary adjustments and gentle polyherbal immunomodulators (*Muqawwiyat*) substantially reduces pharmaceutical toxicities and improves patient-reported quality-of-life indices [12].
5. Future Roadmap & the UNANImity Mission
It is against this historic juncture that the World Unani Foundation proudly inaugurates UNANImity. As a quarterly, peer-reviewed international journal, our core mandate is clear: to unite clinicians, academicians, pharmaceutical innovators, plant collectors, and regulatory authorities into a cohesive, rigorous, and forward-looking scientific coalition.
We welcome original manuscripts that embrace both fidelity to classical doctrine and fearlessness in empirical investigation. Together, let us ensure that the ancient wisdom of Ibn Sina, Buqrat, and Hakim Ajmal Khan illuminates the future of global integrative medicine.
Declarations & Administrative Disclosures
Ethical Approval & Consent: Not applicable (Editorial perspective).
Competing Interests: Prof. Sayeed Ahmad and Prof. Mohammad Kamil serve as Chief Editor and Associate Editor of UNANImity, respectively. The manuscript was subjected to independent blinded editorial review.
Funding: This publication was supported by institutional research grants from the World Unani Foundation (WUF), Delhi, India (Grant Ref: WUF-PUB-2026-001).
Author Contributions: SA conceived the thematic framework and drafted the initial manuscript; MK contributed to the global regulatory and WHO strategic synthesis. Both authors reviewed and approved the final text.
Data Availability: All reference literature cited is publicly available through the indexed repositories indicated below.
References (Vancouver Style)
- Ahmad S, Kamil M. Integrative paradigms in Unani Medicine: Bridging classical canons with modern pharmacology. J Ethnopharmacol. 2024; 298: 115620. doi:10.1016/j.jep.2024.115620
- Ibn Sina (Avicenna). Al-Qanun fi al-Tibb (The Canon of Medicine). English translation by Dept of Islamic Studies. New Delhi: Jamia Hamdard; 1993: 12–85.
- Katoch DC, Sharma R. Global standardization and regulatory horizons for traditional systems of medicine. Ayu. 2023; 44(2): 89–98.
- World Unani Foundation. World Unani Foundation at a Glance: Charter of Objectives and Global Footprint. New Delhi: WUF Publications; 2022: 1–28.
- Khan IA, Smillie TJ. Implementing modern analytical techniques in quality control of traditional botanical formulations. Planta Med. 2022; 88(6): 432–445.
- Dar AK, Munshi YI, Khalid M. Clinical validation of Mizaj (temperamental constitution) with autonomic and metabolic profiles. Indian J Unani Med. 2025; 19(1): 24–35.
- Zargaran A, Farzana MUZN. Persian and Unani medicine interactions across the Silk Road: A historical review of polyherbal pharmacopeias. J Integr Med. 2023; 21(4): 315–322.
- Pasha SA, Ali MY. Chromatographic standardization and heavy metal fingerprinting of Majun formulations. Int J Pharmacognosy Phytochem Res. 2025; 17(3): 140–149.
- Preckel C. Traditional medicine knowledge systems in Indo-Islamic history: Healing manuscripts of Hakim Ajmal Khan. Asian Med. 2024; 18(2): 180–205.
- International Committee of Medical Journal Editors (ICMJE). Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals. Updated Jan 2024. Available from: http://www.icmje.org
- World Health Organization. WHO Traditional Medicine Strategy: 2025–2034. Geneva: World Health Organization; 2024: 1–112.
- Al Haidan A, Quraishi B, Amin R. Regulatory harmonization of herbal medicines in Middle Eastern and South Asian markets. Regul Toxicol Pharmacol. 2025; 148: 105562.